ResMed Financial Statements From 2010 to 2025

RMD Stock  USD 248.95  2.07  0.84%   
ResMed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing ResMed's valuation are provided below:
Gross Profit
3.2 B
Profit Margin
0.2735
Market Capitalization
36 B
Enterprise Value Revenue
7.7755
Revenue
5.3 B
There are over one hundred nineteen available trending fundamental ratios for ResMed Inc, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of ResMed's recent performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 461.4 M. The current year's Enterprise Value is expected to grow to about 451 M

ResMed Total Revenue

5.4 Billion

Check ResMed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ResMed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 247.6 M, Interest Expense of 11.9 M or Total Revenue of 5.4 B, as well as many indicators such as Price To Sales Ratio of 4.31, Dividend Yield of 0.0134 or PTB Ratio of 4.78. ResMed financial statements analysis is a perfect complement when working with ResMed Valuation or Volatility modules.
  
Build AI portfolio with ResMed Stock
Check out the analysis of ResMed Correlation against competitors.

ResMed Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.6 B8.2 B4.2 B
Slightly volatile
Short and Long Term Debt Total465 M882.3 M758.4 M
Slightly volatile
Other Current Liabilities529.2 M504 M239.2 M
Slightly volatile
Total Current Liabilities1.1 BB587.1 M
Slightly volatile
Total Stockholder Equity6.3 BB2.8 B
Slightly volatile
Property Plant And Equipment Net754.2 M718.3 M488.5 M
Slightly volatile
Retained Earnings6.4 B6.1 BB
Slightly volatile
Accounts Payable292.1 M278.2 M129.3 M
Slightly volatile
Cash1.3 B1.2 B573.6 M
Very volatile
Non Current Assets Total4.9 B4.7 B2.5 B
Slightly volatile
Non Currrent Assets Other105.8 M100.8 M86.6 M
Slightly volatile
Cash And Short Term Investments1.3 B1.2 B573.6 M
Very volatile
Net Receivables986.5 M939.5 M519.6 M
Slightly volatile
Common Stock Shares Outstanding148.2 M147.3 M139.6 M
Slightly volatile
Liabilities And Stockholders Equity8.6 B8.2 B4.2 B
Slightly volatile
Non Current Liabilities Total1.2 B1.2 B867.1 M
Slightly volatile
Inventory974.1 M927.7 M449 M
Slightly volatile
Other Current Assets450.4 M429 M209.7 M
Slightly volatile
Total Liabilities2.3 B2.2 B1.5 B
Slightly volatile
Total Current Assets3.7 B3.5 B1.8 B
Slightly volatile
Short Term Debt67.2 M70.9 M80.8 M
Pretty Stable
Intangible Assets488.1 M464.9 M292.1 M
Slightly volatile
Property Plant And Equipment Gross1.5 B1.4 B624.5 M
Slightly volatile
Common Stock Total Equity417 K670.5 K539.8 K
Slightly volatile
Common Stock470.4 K761 K549.6 K
Slightly volatile
Other Assets460.9 M439 M178.7 M
Slightly volatile
Good Will3.2 BB1.5 B
Slightly volatile
Property Plant Equipment414.6 M718.3 M469.6 M
Slightly volatile
Other Liabilities380.6 M362.5 M161.1 M
Slightly volatile
Long Term Debt492.5 M658.4 M646.1 M
Slightly volatile
Current Deferred Revenue174.3 M166 M85.7 M
Slightly volatile
Retained Earnings Total Equity2.3 B3.3 B2.3 B
Slightly volatile
Long Term Debt Total803.3 M658.4 M681.1 M
Slightly volatile
Capital Surpluse1.6 BB1.5 B
Slightly volatile
Non Current Liabilities Other148.6 M141.5 M49.1 M
Slightly volatile
Deferred Long Term Asset Charges42.6 M52.3 M38.7 M
Slightly volatile
Short and Long Term Debt8.5 M8.9 M186.1 M
Slightly volatile
Long Term Investments42 M59.9 M41 M
Slightly volatile
Net Invested Capital4.6 B6.6 B3.8 B
Slightly volatile
Cash And Equivalents1.3 B1.2 B508.1 M
Pretty Stable
Net Working Capital1.3 B2.5 B1.2 B
Pretty Stable
Capital Stock669.6 K761 K595.7 K
Slightly volatile
Capital Lease Obligations163.7 M183.5 M135.3 M
Slightly volatile

ResMed Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization247.6 M235.8 M127.4 M
Slightly volatile
Total Revenue5.4 B5.1 B2.8 B
Slightly volatile
Gross Profit3.2 B3.1 B1.6 B
Slightly volatile
Other Operating Expenses3.6 B3.5 BB
Slightly volatile
Operating Income1.8 B1.7 B753.8 M
Slightly volatile
EBIT1.8 B1.7 B775.2 M
Slightly volatile
EBITDAB1.9 B902.6 M
Slightly volatile
Cost Of Revenue2.2 B2.1 B1.1 B
Slightly volatile
Total Operating Expenses1.4 B1.4 B857.2 M
Slightly volatile
Income Before Tax1.8 B1.7 B741.7 M
Slightly volatile
Net Income1.5 B1.4 B583.8 M
Slightly volatile
Income Tax Expense290.7 M276.8 M157.8 M
Slightly volatile
Selling General AdministrativeB991 M623.1 M
Slightly volatile
Research Development347.8 M331.3 M188.7 M
Slightly volatile
Net Income Applicable To Common Shares1.5 B1.4 B604.3 M
Slightly volatile
Selling And Marketing Expenses4.6 M6.3 M5.4 M
Pretty Stable
Net Income From Continuing Ops1.5 B1.4 B598 M
Slightly volatile
Tax Provision199.3 M276.8 M157.8 M
Slightly volatile
Interest Income2.4 M2.5 M26 M
Very volatile
Reconciled Depreciation195.5 M235.8 M154.2 M
Slightly volatile

ResMed Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow1.7 B1.7 B604.8 M
Slightly volatile
Begin Period Cash Flow323.4 M238.4 M484.7 M
Slightly volatile
Depreciation247.6 M235.8 M140.3 M
Slightly volatile
Capital Expenditures67.8 M89.9 M85 M
Slightly volatile
Total Cash From Operating Activities1.8 B1.8 B691.4 M
Slightly volatile
Net Income1.5 B1.4 B583.8 M
Slightly volatile
End Period Cash Flow1.3 B1.2 B573.6 M
Very volatile
Stock Based Compensation96.2 M91.7 M55 M
Slightly volatile
Issuance Of Capital Stock54.5 M74.4 M43.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.317.35536.1612
Slightly volatile
Dividend Yield0.01340.00820.0125
Slightly volatile
PTB Ratio4.786.34286.92
Pretty Stable
Days Sales Outstanding81.6966.632972.2593
Slightly volatile
Book Value Per Share42.7140.676319.1075
Slightly volatile
Free Cash Flow Yield0.04610.04390.0354
Slightly volatile
Operating Cash Flow Per Share12.5411.93864.7691
Slightly volatile
Stock Based Compensation To Revenue0.02460.01780.0221
Slightly volatile
Capex To Depreciation0.360.38110.7309
Slightly volatile
PB Ratio4.786.34286.92
Pretty Stable
EV To Sales4.277.29176.1736
Slightly volatile
Free Cash Flow Per Share11.8911.32614.1687
Slightly volatile
ROIC0.10.19470.1451
Pretty Stable
Inventory Turnover2.932.25432.9386
Slightly volatile
Net Income Per Share10.029.54724.0233
Slightly volatile
Days Of Inventory On Hand163162131
Slightly volatile
Payables Turnover5.817.51868.6451
Pretty Stable
Sales General And Administrative To Revenue0.340.30.2777
Pretty Stable
Research And Ddevelopement To Revenue0.07870.06440.0713
Slightly volatile
Capex To Revenue0.01660.01750.0353
Slightly volatile
Cash Per Share8.668.24353.987
Very volatile
POCF Ratio23.8621.610530.7063
Slightly volatile
Interest Coverage14013454.4551
Pretty Stable
Payout Ratio0.430.22190.3877
Very volatile
Capex To Operating Cash Flow0.04870.05130.1718
Slightly volatile
PFCF Ratio41.1422.779241.0185
Slightly volatile
Days Payables Outstanding60.848.546145.5308
Slightly volatile
Income Quality0.961.25051.2145
Slightly volatile
ROE0.140.23470.2014
Very volatile
EV To Operating Cash Flow24.6521.423830.9373
Slightly volatile
PE Ratio27.7427.023734.1802
Pretty Stable
Return On Tangible Assets0.320.30040.2185
Slightly volatile
EV To Free Cash Flow43.3522.582341.4119
Slightly volatile
Earnings Yield0.03770.0370.0336
Slightly volatile
Intangibles To Total Assets0.450.42960.3561
Slightly volatile
Current Ratio3.983.43983.2784
Pretty Stable
Receivables Turnover4.05.47785.087
Slightly volatile
Graham Number98.1593.475841.4939
Slightly volatile
Shareholders Equity Per Share42.7140.676319.1065
Slightly volatile
Debt To Equity0.220.14780.2998
Very volatile
Capex Per Share0.340.61250.581
Slightly volatile
Revenue Per Share36.8335.076819.0592
Slightly volatile
Interest Debt Per Share6.46.09975.4386
Slightly volatile
Debt To Assets0.130.10790.1799
Very volatile
Enterprise Value Over EBITDA14.8419.612221.0647
Pretty Stable
Short Term Coverage Ratios41.1843.34971.9 K
Slightly volatile
Price Earnings Ratio27.7427.023734.1802
Pretty Stable
Operating Cycle244229204
Slightly volatile
Price Book Value Ratio4.786.34286.92
Pretty Stable
Days Of Payables Outstanding60.848.546145.5308
Slightly volatile
Dividend Payout Ratio0.430.22190.3877
Very volatile
Price To Operating Cash Flows Ratio23.8621.610530.7063
Slightly volatile
Price To Free Cash Flows Ratio41.1422.779241.0185
Slightly volatile
Pretax Profit Margin0.180.3260.2427
Slightly volatile
Ebt Per Ebit1.130.99541.0514
Slightly volatile
Operating Profit Margin0.170.32750.2388
Slightly volatile
Effective Tax Rate0.310.1650.2381
Very volatile
Company Equity Multiplier1.221.36971.5628
Pretty Stable
Long Term Debt To Capitalization0.140.09940.1876
Pretty Stable
Total Debt To Capitalization0.150.12880.2147
Very volatile
Return On Capital Employed0.140.23550.1951
Pretty Stable
Debt Equity Ratio0.220.14780.2998
Very volatile
Ebit Per Revenue0.170.32750.2388
Slightly volatile
Quick Ratio3.22.52952.5632
Slightly volatile
Dividend Paid And Capex Coverage Ratio4.594.37082.656
Very volatile
Net Income Per E B T0.580.8350.755
Very volatile
Cash Ratio1.461.18681.2772
Slightly volatile
Cash Conversion Cycle133180155
Slightly volatile
Operating Cash Flow Sales Ratio0.360.34040.2381
Pretty Stable
Days Of Inventory Outstanding163162131
Slightly volatile
Days Of Sales Outstanding81.6966.632972.2593
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.00.94870.8312
Slightly volatile
Cash Flow Coverage Ratios1.861.98521.2249
Pretty Stable
Price To Book Ratio4.786.34286.92
Pretty Stable
Fixed Asset Turnover5.987.16475.9834
Very volatile
Capital Expenditure Coverage Ratio20.4719.49137.8563
Slightly volatile
Price Cash Flow Ratio23.8621.610530.7063
Slightly volatile
Enterprise Value Multiple14.8419.612221.0647
Pretty Stable
Debt Ratio0.130.10790.1799
Very volatile
Cash Flow To Debt Ratio1.861.98521.2249
Pretty Stable
Price Sales Ratio4.317.35536.1612
Slightly volatile
Return On Assets0.0960.17140.1291
Very volatile
Asset Turnover0.80.62960.722
Slightly volatile
Net Profit Margin0.290.27220.1964
Slightly volatile
Gross Profit Margin0.670.59360.5954
Pretty Stable
Price Fair Value4.786.34286.92
Pretty Stable
Return On Equity0.140.23470.2014
Very volatile

ResMed Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap461.4 M439.5 M455.3 M
Slightly volatile
Enterprise Value451 M429.5 M444.8 M
Slightly volatile

ResMed Fundamental Market Drivers

Forward Price Earnings25.9067
Cash And Short Term Investments1.2 B

ResMed Upcoming Events

25th of April 2024
Upcoming Quarterly Report
View
1st of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
1st of August 2024
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About ResMed Financial Statements

ResMed stakeholders use historical fundamental indicators, such as ResMed's revenue or net income, to determine how well the company is positioned to perform in the future. Although ResMed investors may analyze each financial statement separately, they are all interrelated. For example, changes in ResMed's assets and liabilities are reflected in the revenues and expenses on ResMed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ResMed Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue166 M174.3 M
Total Revenue5.1 B5.4 B
Cost Of Revenue2.1 B2.2 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.30  0.34 
Research And Ddevelopement To Revenue 0.06  0.08 
Capex To Revenue 0.02  0.02 
Revenue Per Share 35.08  36.83 
Ebit Per Revenue 0.33  0.17 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
Check out the analysis of ResMed Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.123
Dividend Share
2.19
Earnings Share
9.78
Revenue Per Share
35.875
Quarterly Revenue Growth
0.091
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.